No insider purchase over the last 90 days. The latest was filed 09 Apr 2026.
Sandoz Group AG, classified in the Health Care sector, is a listed company based in Basel, Switzerland, founded in 1886. Its latest reported headcount is 5,724 employees (2023). Its insiders report their share dealings to SIX SER. The last twelve months, up to 18 October 2026, brought 11 filings signed by 3 insiders.
Both sides are active: 6 purchases worth €652k and 5 sales worth €1.3M, from 1 insider and 2 insiders respectively. Sales outweigh purchases by €650k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. On the buying side, the filings list 1 senior executive among the declarants. At €669k, the sale published on 3 November 2025 is the largest of the period.
The most recent open-market purchase was published on 9 April 2026, 192 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. Until a filing is published, the market cannot know about the trade.
With 11 filings in twelve months, the company is more active than the median of 9 filings across the 178 companies we follow on the same exchange. Over the whole record (from 2023), the tally stands at 23 purchases and 8 sales.
In the same sector, recent insider purchases at Cooper Companies, Inc. and Anixa Biosciences Inc also feature in our signals. Source: insider filings from SIX SER. Past trades are no guide to future returns.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Sandoz Group AG Buy (bullish), based on 16 analysts. Average price target: CHF 75.12.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 31 declarations
Sandoz Group AG is a pharmaceutical company specializing in generic and biosimilar medicines. It is part of the Novartis group and is listed on the Swiss stock exchange.
Purchases our model currently ranks for the recommendations list.
All recommendationsHeadquarters: Basel, Switzerland · Founded: 1886 · 5,724 employees (2023) · Wikipedia article
Source: Wikidata (CC0).